Related Experiment Video
Updated: Jul 3, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Regulation of immunity in bronchiectasis
1Imperial College London, National Heart & Lung Institute, London, UK. r.boyton@imperial.ac.uk
Medical Mycology
|July 9, 2008
Summary
Bronchiectasis is a chronic lung disease characterized by irreversible airway dilation and inflammation. Immune system abnormalities, particularly involving natural killer (NK) cells and specific genetic factors, may predispose individuals to this condition.
Area of Science:
- Pulmonology
- Immunology
- Genetics
Background:
- Bronchiectasis is a chronic, progressive lung disease defined by irreversible bronchial dilation, chronic inflammation, cough, sputum, recurrent infections, and airflow obstruction.
- It represents a pathological endpoint with diverse underlying causes, including Allergic Bronchopulmonary Aspergillosis (ABPA).
- Diagnosis involves clinical assessment and High-Resolution Computed Tomography (HRCT) of the thorax.
Purpose of the Study:
- To explore the role of immune system abnormalities in the pathogenesis of bronchiectasis.
- To investigate the potential link between natural killer (NK) cell activation and bronchiectasis susceptibility.
- To examine the association of specific genetic factors with idiopathic bronchiectasis.
Main Methods:
- Review of existing literature on bronchiectasis pathogenesis.
- Analysis of immunogenetic evidence, including natural killer (NK) cell activation.
- Examination of genetic associations, such as HLA-DR1, DQ5, with idiopathic bronchiectasis.
Main Results:
- Bronchiectasis progression is driven by a cycle of recurrent bacterial infection and dysregulated inflammation.
- Abnormalities in both innate and adaptive immunity are implicated in disease susceptibility.
- Evidence suggests a link between natural killer (NK) cell activation and innate immune predisposition.
- Genetic associations, including HLA-DR1, DQ5, point to adaptive immune mechanisms in idiopathic bronchiectasis.
Conclusions:
- Immune system dysregulation plays a critical role in the development and progression of bronchiectasis.
- Innate immunity, potentially via natural killer (NK) cell activation, and adaptive immunity, indicated by genetic factors, are key predisposing mechanisms.
- Understanding these immune links is crucial for developing targeted therapies for bronchiectasis.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation